Viatris to Buy Pacira BioSciences for $1.65 Billion

Date:




Viatris has agreed to buy pain-drug maker Pacira BioSciences for $1.65 billion in a deal that expands the healthcare company’s medicines portfolio.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Opinion | Just Another Frantic Friday at the FAA

Travel woes will persist until Congress reforms the air-traffic...

High schoolers across New Mexico, Texas compete to fabricate chili roasters from sheet metal

ALBUQUERQUE, N.M. (KRQE) – High schoolers from across New Mexico,...

Czechs gather in big numbers to reject government’s plan to overhaul funding of public media

PRAGUE -- Hundreds of thousands of people rallied in...